Cargando…

Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [(18)F]-L-FBPA positron emission tomography in boron neutron capture therapy

BACKGROUND: Boron neutron capture therapy (BNCT) is a cellular-level particle radiation therapy that combines the selective delivery of boron compounds to tumour tissue with neutron irradiation. L-p-Boronophenylalanine (L-BPA) is a boron compound now widely used in clinical situations. Determination...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Tsubasa, Hattori, Yoshihide, Ohta, Youichiro, Ishimura, Miki, Nakagawa, Yosuke, Sanada, Yu, Tanaka, Hiroki, Fukutani, Satoshi, Masunaga, Shin-ichiro, Hiraoka, Masahiro, Ono, Koji, Suzuki, Minoru, Kirihata, Mitsunori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100278/ https://www.ncbi.nlm.nih.gov/pubmed/27821116 http://dx.doi.org/10.1186/s12885-016-2913-x

Ejemplares similares

Practical calculation method to estimate the absolute boron concentration in tissues using (18)F-FBPA PET
por: Watabe, Tadashi, et al.
Publicado: (2017)

Development and Elucidation of a Novel Fluorescent Boron-Sensor for the Analysis of Boronic Acid-Containing Compounds
por: Hattori, Yoshihide, et al.
Publicado: (2017)

Time-series clustering of gene expression in irradiated and bystander fibroblasts: an application of FBPA clustering
por: Ghandhi, Shanaz A, et al.
Publicado: (2011)

Bordetella pertussis FbpA Binds Both Unchelated Iron and Iron Siderophore Complexes
por: Banerjee, Sambuddha, et al.
Publicado: (2014)

(18)F-FBPA PET in Sarcoidosis: Comparison to Inflammation-Related Uptake on FDG PET
por: Watabe, Tadashi, et al.
Publicado: (2020)

Exploration of the threshold SUV for diagnosis of malignancy using (18)F-FBPA PET/CT
por: Isohashi, Kayako, et al.
Publicado: (2022)

Comparison of Conventional and Radiomic Features between (18)F-FBPA PET/CT and PET/MR
por: Liao, Chien-Yi, et al.
Publicado: (2021)

Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
por: Susidarti, Ratna Asmah, et al.
Publicado: (2019)

FBPA PET in boron neutron capture therapy for cancer: prediction of (10)B concentration in the tumor and normal tissue in a rat xenograft model
por: Hanaoka, Kohei, et al.
Publicado: (2014)

Borrelia miyamotoi FbpA and FbpB Are Immunomodulatory Outer Surface Lipoproteins With Distinct Structures and Functions
por: Booth, Charles E., et al.
Publicado: (2022)

The fbpA/sapM Double Knock Out Strain of Mycobacterium tuberculosis Is Highly Attenuated and Immunogenic in Macrophages
por: Saikolappan, Sankaralingam, et al.
Publicado: (2012)

Evaluation of the total distribution volume of (18)F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling
por: Romanov, Victor, et al.
Publicado: (2019)

Antibody-Based Receptor Targeting Using an Fc-Binding Peptide-Dodecaborate Conjugate and Macropinocytosis Induction for Boron Neutron Capture Therapy
por: Nakase, Ikuhiko, et al.
Publicado: (2020)

Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-(18)F-fluoro-phenylalanine (FBPA) PET study
por: Isohashi, Kayako, et al.
Publicado: (2016)

Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET
por: Tatsumi, Mitsuaki, et al.
Publicado: (2022)

Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy
por: Takeuchi, Koji, et al.
Publicado: (2020)

The impact of TP53 status of tumor cells including the type and the concentration of administered (10)B delivery agents on compound biological effectiveness in boron neutron capture therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2023)

Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy
por: Watanabe, Tsubasa, et al.
Publicado: (2022)

Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma
por: Futamura, Gen, et al.
Publicado: (2017)

Evaluation of the Potential of p‐Boronophenylalaninol as a Boron Carrier in Boron Neutron Capture Therapy, Referring to the Effect on Intratumor Quiescent Cells
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2001)

The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model
por: Fukuo, Yusuke, et al.
Publicado: (2020)

Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer
por: Utomo, Rohmad Yudi, et al.
Publicado: (2022)

Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model
por: Kashiwagi, Hideki, et al.
Publicado: (2023)

Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis
por: Mulder, Christiaan, et al.
Publicado: (2022)

Impact of oxygen status on (10)B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy
por: Wada, Yuki, et al.
Publicado: (2018)

Theranostics in Boron Neutron Capture Therapy
por: Sauerwein, Wolfgang A. G., et al.
Publicado: (2021)

Are BPA Substitutes as Obesogenic as BPA?
por: Oliviero, Fabiana, et al.
Publicado: (2022)

Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry Imaging of L-4-Phenylalanineboronic Acid (BPA) in a Brain Tumor Model Rat for Boron Neutron Capture Therapy (BNCT)
por: Miyake, Yumi, et al.
Publicado: (2022)

Growth and Distribution of Boron in Oilseed Rape (Brassica napus L.) as Affected by Boron Supply
por: Dinh, Anh Quang, et al.
Publicado: (2022)

Pathway selection in the self-assembly of Rh(4)L(4) coordination squares under kinetic control
por: Okazawa, Atsushi, et al.
Publicado: (2023)

Boron accumulation by Lemna minor L. under salt stress
por: Liu, Chunguang, et al.
Publicado: (2018)

Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients
por: van de Berg, S. E. J., et al.
Publicado: (2021)

Prenatal Exposure to BPA and Offspring Outcomes: The Diabesogenic Behavior of BPA
por: Alonso-Magdalena, Paloma, et al.
Publicado: (2015)

Tailored hyaluronic acid-based nanogels as theranostic boron delivery systems for boron neutron cancer therapy
por: Coninx, Simon, et al.
Publicado: (2022)

1400. Pretomanid in the Treatment of Patients with Tuberculosis in the United States: the Bedaquiline, Pretomanid and Linezolid (BPaL) Accelerated Monitoring (BAM) Project
por: Goswami, Neela, et al.
Publicado: (2021)

Luminescent Hybrid BPA.DA-NVP@Eu(2)L(3) Materials: In Situ Synthesis, Spectroscopic, Thermal, and Mechanical Characterization
por: Vlasyuk, Dmytro, et al.
Publicado: (2023)

Tetraploidy Enhances Boron-Excess Tolerance in Carrizo Citrange (Citrus sinensis L. Osb. × Poncirus trifoliata L. Raf.)
por: Ruiz, Marta, et al.
Publicado: (2016)

L3: Decay of Z0 to positron-electron pair
Publicado: (1991)

Effects of BPA in Snails
por: Dietrich, Daniel R., et al.
Publicado: (2006)

Targeted Molecular Construct for Bioorthogonal Theranostics of PD-L1-Expressing Cancer Cells
por: Chow, Shiao Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_glbab7kvcu1mf0jrdcq3ubcg1l